hrp0086p2-p269 | Diabetes P2 | ESPE2016
Ben-Skowronek Iwona
, Piekarski Robert
, Wysocka Beata
, Bury Anna
, Banecka Bozena
, Krzewska Aleksandra
, Sieniawska Joanna
, Kabat Magdalena
, Rebowicz Katarzyna
, Osiak Wiktoria
, Szewczyk Leszek
Background: CSII has some potential advantages and disadvantages for young children. For many young patients, it is easier and more convenient to take multiple daily doses of insulin with CSII than with a syringe or insulin pen.Objective and hypotheses: The growing popularity of type 1 diabetes (DM1) treatment based on continuous subcutaneous insulin infusion (CSII) raises a question of the group of patients that benefit most from the treatment.<p cl...